Table III.
Drugs | Dose (mg/m2) | Route | Days |
---|---|---|---|
PAC (6 cycles)a | |||
Cisplatin | 80 | i.v. | 1 |
Doxorubicin | 80 | i.v. | 1 |
Cyclophosphamide | 800 | i.v. | 1 |
ICE (6 cycles)a | |||
Ifosfamide | 1500 | i.v. | 1 |
Carboplatin | 150 | i.v. | 1 |
Etoposide | 150 | i.v. | 1–3 |
PEV (6 cycles)a | |||
Cisplatin | 75 | i.v. | 1 |
Epirubicin | 100 | i.v. | 1 |
Etoposide | 120 | i.v. | 1 |
Docetaxel (6 cycles)b | |||
Docetaxel | 90 | i.v. | 1 |
P-DOX-SL (8 cycles)b | |||
Liposomal doxorubicinc | 50 | i.v. | 1 |
Cisplatin | 60 | i.v. | 1 |
VMN (8 cycles)b | |||
Vinorelbine | 50 | i.v. | 1 |
Methotrexate | 100 | i.v. | 1 |
Mitoxantronea | 16 | i.v. | 1 |
Repeated every 21 days.
Repeated every 15 days.
Mitoxantrone was administered at variably reduced doses.